Evidence map›Paper›PMID 38883729›Full record

ArticlemedRxiv : the preprint server for health sciences2024

Dysfunction of proprioceptive sensory synapses is a pathogenic event and therapeutic target in mice and humans with spinal muscular atrophy.

C M Simon, N Delestree, J Montes, F Gerstner, E Carranza, L Sowoidnich, J M Buettner, J G Pagiazitis, G Prat-Ortega, S Ensel and 11 more

Abstract readPreprint
In one paragraph

Article in medRxiv : the preprint server for health sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

21 authors.

C M SimonCenter for Motor Neuron Biology and Disease, Columbia University, NY, USA.
N DelestreeCenter for Motor Neuron Biology and Disease, Columbia University, NY, USA.
J MontesCenter for Motor Neuron Biology and Disease, Columbia University, NY, USA.
F GerstnerCarl-Ludwig-Institute for Physiology, Leipzig University, Leipzig, Germany.
E CarranzaDepts. Physical Medicine & Rehabilitation & Bioengineering, University of Pittsburgh, PA, USA.
L SowoidnichCarl-Ludwig-Institute for Physiology, Leipzig University, Leipzig, Germany.
J M BuettnerCarl-Ludwig-Institute for Physiology, Leipzig University, Leipzig, Germany.
J G PagiazitisCenter for Motor Neuron Biology and Disease, Columbia University, NY, USA.
G Prat-OrtegaRehab and Neural Engineering Labs, University of Pittsburgh, PA, USA.
S EnselRehab and Neural Engineering Labs, University of Pittsburgh, PA, USA.
S DonadioRehab and Neural Engineering Labs, University of Pittsburgh, PA, USA.
J L GarciaDept. of Neurology, Columbia University, NY, USA.
P KratimenosCenter for Neuroscience Research, Children's National Res. Institute, Washington, DC, USA.
W K ChungDept. of Pediatrics, Boston Children's Hospital and Harvard Medical School, Boston, MA USA.
C J SumnerDepts. of Neurology, Neuroscience and Genetic Medicine, Johns Hopkins University School of Medicine, MD, USA.
L H WeimerDept. of Neurology, Columbia University, NY, USA.
E PirondiniDepts. Physical Medicine & Rehabilitation & Bioengineering, University of Pittsburgh, PA, USA.
M CapogrossoRehab and Neural Engineering Labs, University of Pittsburgh, PA, USA.ORCID 0000-0002-0975-316X
L PellizzoniCenter for Motor Neuron Biology and Disease, Columbia University, NY, USA.
D C De VivoCenter for Motor Neuron Biology and Disease, Columbia University, NY, USA.
G Z MentisCenter for Motor Neuron Biology and Disease, Columbia University, NY, USA.ORCID 0000-0002-4610-2016

Funding

Child Health Research Career Development Award (CHRCDA) Program at Children's NationalK12HD001399 · NICHD · CHILDREN'S RESEARCH INSTITUTE · PI NATHAN KUPPERMANN · 2001 to 2026
$9.1M
Mechanisms of Central Synaptic Dysfunction in SMAR01NS078375 · NINDS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI George Z Mentis · 2012 to 2026
$6.6M
Translating Pathomechanisms into Treatment for Spinal Muscular AtrophiesR35NS122306 · NINDS · JOHNS HOPKINS UNIVERSITY · PI Charlotte Jane Sumner · 2021 to 2026
$6.3M
RNA-Mediated Mechanisms of Motor System Dysfunction in Spinal Muscular AtrophyR01NS102451 · NINDS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI Livio Pellizzoni · 2017 to 2026
$3.9M
Mechanisms of synaptic loss by the classical complement pathway in motor circuit development and diseaseR01AA027079 · NIAAA · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI MENTIS, GEORGE Z · 2018 to 2022
$3.2M
Essential role of Stasimon in motor circuit development and diseaseR01NS114218 · NINDS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI PELLIZZONI, LIVIO · 2020 to 2024
$2.9M
Cellular and Neuronal Circuit Mechanisms Involved in Locomotor ActivityR01NS125362 · NINDS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI George Z Mentis · 2023 to 2026
$2.5M
Mechanisms and Therapeutic Targeting of Motor Neuron Death in SMAR01NS116400 · NINDS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI PELLIZZONI, LIVIO · 2020 to 2024
$2.3M
Evaluation of Oxidative Capacity and Exercise Tolerance in Ambulatory Patients with Spinal Muscular AtrophyK01HD084690 · NICHD · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI MONTES, JACQUELINE · 2016 to 2020
$651k
NIAAA NIH HHS R01 AA027079NICHD NIH HHS K01 HD084690NICHD NIH HHS K12 HD001399NINDS NIH HHS R01 NS078375NINDS NIH HHS R01 NS102451NINDS NIH HHS R01 NS114218NINDS NIH HHS R01 NS116400NINDS NIH HHS R01 NS125362NINDS NIH HHS R35 NS122306
6 · The paper itself

Abstract

Spinal muscular atrophy (SMA) is a neurodegenerative disease characterized by a varying degree of severity that correlates with the reduction of SMN protein levels. Motor neuron degeneration and skeletal muscle atrophy are hallmarks of SMA, but it is unknown whether other mechanisms contribute to the spectrum of clinical phenotypes. Here, through a combination of physiological and morphological studies in mouse models and SMA patients, we identify dysfunction and loss of proprioceptive sensory synapses as key signatures of SMA pathology. We demonstrate that SMA patients exhibit impaired proprioception, and their proprioceptive sensory synapses are dysfunctional as measured by the neurophysiological test of the Hoffmann reflex (H-reflex). We further show that loss of excitatory afferent synapses and altered potassium channel expression in SMA motor neurons are conserved pathogenic events found in both severely affected patients and mouse models. Lastly, we report that improved motor function and fatigability in ambulatory SMA patients and mouse models treated with SMN-inducing drugs correlate with increased function of sensory-motor circuits that can be accurately captured by the H-reflex assay. Thus, sensory synaptic dysfunction is a clinically relevant event in SMA, and the H-reflex is a suitable assay to monitor disease progression and treatment efficacy of motor circuit pathology.

Identifiers

PMID38883729
PMCPMC11177917

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.